SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4odj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BRP_A_RTLA183_0 (RETINOL BINDING PROTEIN)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 12	LEU A 323 GLY A 281 PHE A 25 TYR A 279 PHE A 343	None	1.29A	1brpA-4odjA: undetectable	1brpA-4odjA: 18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FB7_A_ROCA100_1 (HIV-1 PROTEASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 12	GLY A 268 ASP A 40 GLY A 33 THR A 91 VAL A 88	None	0.97A	1fb7A-4odjA: undetectable	1fb7A-4odjA: 13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KNY_A_KANA558_1 (KANAMYCIN NUCLEOTIDYLTRANSFERA SE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	4 / 7	SER A 43 ASP A 44 GLU A 62 GLU A 75	None	1.07A	1knyA-4odjA: undetectable 1knyB-4odjA: undetectable	1knyA-4odjA: 20.43 1knyB-4odjA: 20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KNY_B_KANB559_1 (KANAMYCIN NUCLEOTIDYLTRANSFERA SE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	4 / 8	SER A 43 ASP A 44 GLU A 62 GLU A 75	None	1.13A	1knyA-4odjA: undetectable 1knyB-4odjA: undetectable	1knyA-4odjA: 20.43 1knyB-4odjA: 20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OHR_A_1UNA201_1 (ASPARTYLPROTEASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	6 / 11	ASP A 36 ASP A 40 GLY A 33 THR A 91 VAL A 88 ILE A 42	MG A 502 ( 2.5A) None None None None None	1.32A	1ohrA-4odjA: undetectable	1ohrA-4odjA: 15.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC685_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.29A	1p7lC-4odjA: 56.0	1p7lC-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC685_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.42A	1p7lD-4odjA: 56.0	1p7lD-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC885_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.43A	1p7lC-4odjA: 56.0	1p7lC-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1P7L_C_SAMC885_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.28A	1p7lD-4odjA: 56.0	1p7lD-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_A_SAMA385_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	1rg9A-4odjA: 56.1	1rg9A-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_A_SAMA385_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.43A	1rg9B-4odjA: 56.1	1rg9B-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_B_SAMB485_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.43A	1rg9A-4odjA: 56.1	1rg9A-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_B_SAMB485_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	1rg9B-4odjA: 56.1	1rg9B-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC585_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.33A	1rg9C-4odjA: 56.0	1rg9C-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC585_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.41A	1rg9D-4odjA: 56.0	1rg9D-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC685_0 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.43A	1rg9C-4odjA: 56.0	1rg9C-4odjA: 47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1RG9_C_SAMC685_1 (S-ADENOSYLMETHIONINE SYNTHETASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	1rg9D-4odjA: 56.0	1rg9D-4odjA: 47.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FL5_B_RBFB202_1 (IMMUNOGLOBULIN IGG1 LAMBDA LIGHT CHAIN IMMUNOGLOBULIN IGG1 HEAVY CHAIN)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 11	GLY A 261 PRO A 263 GLU A 101 VAL A 92 TYR A 97	None	1.48A	2fl5A-4odjA: undetectable 2fl5B-4odjA: undetectable 2fl5F-4odjA: undetectable	2fl5A-4odjA: 19.06 2fl5B-4odjA: 22.25 2fl5F-4odjA: 22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NNP_A_ROCA401_1 (PROTEASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 11	GLY A 268 ASP A 40 GLY A 33 THR A 91 VAL A 88	None	0.93A	2nnpA-4odjA: undetectable	2nnpA-4odjA: 15.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OBV_A_SAMA501_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.25A	2obvA-4odjA: 60.2	2obvA-4odjA: 55.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P02_A_SAMA2_0 (S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.28A	2p02A-4odjA: 60.1	2p02A-4odjA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K0B_B_SAMB504_1 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-3.3A)	0.33A	4k0bB-4odjA: 26.7	4k0bB-4odjA: 25.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.29A	4kttA-4odjA: 53.0	4kttA-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_C_SAMC404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	4kttC-4odjA: 52.8	4kttC-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTT_C_SAMC404_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.20A	4kttD-4odjA: 59.6	4kttD-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_A_ADNA403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 12	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.68A	4ktvA-4odjA: 53.0 4ktvB-4odjA: 58.8	4ktvA-4odjA: 56.28 4ktvB-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4KTV_C_ADNC403_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 11	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.43A	4ktvC-4odjA: 52.8 4ktvD-4odjA: 58.8	4ktvC-4odjA: 56.28 4ktvD-4odjA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L7I_B_SAMB501_1 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-3.3A)	0.33A	4l7iB-4odjA: 26.3	4l7iB-4odjA: 25.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_A_SAMA407_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.29A	4ndnA-4odjA: 53.4	4ndnA-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_A_SAMA407_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.37A	4ndnB-4odjA: 59.6	4ndnB-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_C_SAMC405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	4ndnC-4odjA: 53.3	4ndnC-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NDN_C_SAMC405_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.20A	4ndnD-4odjA: 59.7	4ndnD-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ODJ_A_SAMA500_0 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.00A	4odjA-4odjA: 70.0	4odjA-4odjA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_A_SHHA404_2 (HISTONE DEACETYLASE 8)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	3 / 3	PRO A 156 MET A 155 TYR A 279	None	0.77A	4qa0B-4odjA: undetectable	4qa0B-4odjA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_B_SHHB404_1 (HISTONE DEACETYLASE 8)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	3 / 3	PRO A 156 MET A 155 TYR A 279	None	0.75A	4qa0A-4odjA: undetectable	4qa0A-4odjA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA2_A_SHHA404_2 (HISTONE DEACETYLASE 8)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	3 / 3	PRO A 156 MET A 155 TYR A 279	None	0.86A	4qa2B-4odjA: undetectable	4qa2B-4odjA: 21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 11	GLY A 388 GLY A 387 SER A 386 ASP A 170 SER A 32	None	1.07A	4qvwK-4odjA: undetectable 4qvwL-4odjA: undetectable	4qvwK-4odjA: 21.65 4qvwL-4odjA: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	5 / 11	GLY A 388 GLY A 387 SER A 386 ASP A 170 SER A 32	None	1.07A	4qvwY-4odjA: undetectable 4qvwZ-4odjA: undetectable	4qvwY-4odjA: 21.65 4qvwZ-4odjA: 18.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5A1I_A_ADNA407_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	5a1iA-4odjA: 60.2	5a1iA-4odjA: 56.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5A1I_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.25A	5a1iA-4odjA: 60.2	5a1iA-4odjA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JH7_B_6K9B503_1 (TUBULIN ALPHA-1B CHAIN TUBULIN BETA-2B CHAIN)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	4 / 7	LEU A 231 VAL A 234 GLU A 168 ILE A 221	None	1.20A	5jh7C-4odjA: undetectable	5jh7C-4odjA: 21.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8S_B_SAMB402_0 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	ALA A 60 GLU A 75 GLN A 118 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.18A	5t8sA-4odjA: 57.9	5t8sA-4odjA: 50.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5T8S_B_SAMB402_1 (S-ADENOSYLMETHIONINE SYNTHASE)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.15A	5t8sB-4odjA: 55.3	5t8sB-4odjA: 50.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBN_B_SAMB401_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	6 / 7	ALA A 60 GLU A 75 ILE A 122 ASP A 139 LYS A 297 ILE A 330	None	0.32A	6fbnA-4odjA: 58.0	6fbnA-4odjA: 56.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FBN_B_SAMB401_1 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.24A	6fbnB-4odjA: 52.0	6fbnB-4odjA: 56.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FBO_A_ADNA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.23A	6fboA-4odjA: 60.4	6fboA-4odjA: 12.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FBP_B_ADNB404_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 12	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.31A	6fbpA-4odjA: 60.1 6fbpB-4odjA: 53.6	6fbpA-4odjA: 12.32 6fbpB-4odjA: 12.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6FCB_A_SAMA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.32A	6fcbA-4odjA: 59.9	6fcbA-4odjA: 56.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FCD_A_ADNA405_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	8 / 8	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 214 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 ( 4.0A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.23A	6fcdA-4odjA: 60.0	6fcdA-4odjA: 12.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_ACTA821_0 (GEPHYRIN)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	3 / 3	ARG A 392 PHE A 390 GLY A 388	None	0.73A	6fgdA-4odjA: undetectable	6fgdA-4odjA: 21.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6G6R_A_SAMA406_0 (S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2)	4odj	S-ADENOSYLMETHIONINE SYNTHASE (Cryptosporidium hominis)	7 / 7	HIS A 34 PRO A 35 ASP A 187 LYS A 189 SER A 255 PHE A 258 ASP A 266	SAM A 500 ( 3.8A) SAM A 500 (-4.3A) SAM A 500 (-2.8A) 3PO A 501 ( 2.7A) SAM A 500 (-2.7A) SAM A 500 (-3.5A) SAM A 500 (-3.3A)	0.25A	6g6rA-4odjA: 60.3	6g6rA-4odjA: 56.28

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BRP_A_RTLA183_0","RETINOL BINDING PROTEIN","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"LEU A 323;GLY A 281;PHE A  25;TYR A 279;PHE A 343","None","1.29A","1brpA-4odjA:undetectable","1brpA-4odjA:18.38"],["1FB7_A_ROCA100_1","HIV-1 PROTEASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"GLY A 268;ASP A  40;GLY A  33;THR A  91;VAL A  88","None","0.97A","1fb7A-4odjA:undetectable","1fb7A-4odjA:13.88"],["1KNY_A_KANA558_1","KANAMYCIN NUCLEOTIDYLTRANSFERASE;KANAMYCIN NUCLEOTIDYLTRANSFERASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",4,"SER A  43;ASP A  44;GLU A  62;GLU A  75","None","1.07A","1knyA-4odjA:undetectable;1knyB-4odjA:undetectable","1knyA-4odjA:20.43;1knyB-4odjA:20.43"],["1KNY_B_KANB559_1","KANAMYCIN NUCLEOTIDYLTRANSFERASE;KANAMYCIN NUCLEOTIDYLTRANSFERASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",4,"SER A  43;ASP A  44;GLU A  62;GLU A  75","None","1.13A","1knyA-4odjA:undetectable;1knyB-4odjA:undetectable","1knyA-4odjA:20.43;1knyB-4odjA:20.43"],["1OHR_A_1UNA201_1","ASPARTYLPROTEASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",6,"ASP A  36;ASP A  40;GLY A  33;THR A  91;VAL A  88;ILE A  42"," MG A 502 ( 2.5A);None;None;None;None;None","1.32A","1ohrA-4odjA:undetectable","1ohrA-4odjA:15.56"],["1P7L_C_SAMC685_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.29A","1p7lC-4odjA:56.0","1p7lC-4odjA:47.94"],["1P7L_C_SAMC685_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.42A","1p7lD-4odjA:56.0","1p7lD-4odjA:47.94"],["1P7L_C_SAMC885_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.43A","1p7lC-4odjA:56.0","1p7lC-4odjA:47.94"],["1P7L_C_SAMC885_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.28A","1p7lD-4odjA:56.0","1p7lD-4odjA:47.94"],["1RG9_A_SAMA385_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","1rg9A-4odjA:56.1","1rg9A-4odjA:47.94"],["1RG9_A_SAMA385_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.43A","1rg9B-4odjA:56.1","1rg9B-4odjA:47.94"],["1RG9_B_SAMB485_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.43A","1rg9A-4odjA:56.1","1rg9A-4odjA:47.94"],["1RG9_B_SAMB485_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","1rg9B-4odjA:56.1","1rg9B-4odjA:47.94"],["1RG9_C_SAMC585_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.33A","1rg9C-4odjA:56.0","1rg9C-4odjA:47.94"],["1RG9_C_SAMC585_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.41A","1rg9D-4odjA:56.0","1rg9D-4odjA:47.94"],["1RG9_C_SAMC685_0","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.43A","1rg9C-4odjA:56.0","1rg9C-4odjA:47.94"],["1RG9_C_SAMC685_1","S-ADENOSYLMETHIONINE SYNTHETASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","1rg9D-4odjA:56.0","1rg9D-4odjA:47.94"],["2FL5_B_RBFB202_1","IMMUNOGLOBULIN IGG1 LAMBDA LIGHT CHAIN;IMMUNOGLOBULIN IGG1 HEAVY CHAIN;IMMUNOGLOBULIN IGG1 HEAVY CHAIN","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"GLY A 261;PRO A 263;GLU A 101;VAL A  92;TYR A  97","None","1.48A","2fl5A-4odjA:undetectable;2fl5B-4odjA:undetectable;2fl5F-4odjA:undetectable","2fl5A-4odjA:19.06;2fl5B-4odjA:22.25;2fl5F-4odjA:22.25"],["2NNP_A_ROCA401_1","PROTEASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"GLY A 268;ASP A  40;GLY A  33;THR A  91;VAL A  88","None","0.93A","2nnpA-4odjA:undetectable","2nnpA-4odjA:15.85"],["2OBV_A_SAMA501_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.25A","2obvA-4odjA:60.2","2obvA-4odjA:55.90"],["2P02_A_SAMA2_0","S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.28A","2p02A-4odjA:60.1","2p02A-4odjA:56.28"],["4K0B_B_SAMB504_1","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-3.3A)","0.33A","4k0bB-4odjA:26.7","4k0bB-4odjA:25.11"],["4KTT_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.29A","4kttA-4odjA:53.0","4kttA-4odjA:56.28"],["4KTT_C_SAMC404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","4kttC-4odjA:52.8","4kttC-4odjA:56.28"],["4KTT_C_SAMC404_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.20A","4kttD-4odjA:59.6","4kttD-4odjA:56.28"],["4KTV_A_ADNA403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.68A","4ktvA-4odjA:53.0;4ktvB-4odjA:58.8","4ktvA-4odjA:56.28;4ktvB-4odjA:56.28"],["4KTV_C_ADNC403_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2;S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.43A","4ktvC-4odjA:52.8;4ktvD-4odjA:58.8","4ktvC-4odjA:56.28;4ktvD-4odjA:56.28"],["4L7I_B_SAMB501_1","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-3.3A)","0.33A","4l7iB-4odjA:26.3","4l7iB-4odjA:25.11"],["4NDN_A_SAMA407_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.29A","4ndnA-4odjA:53.4","4ndnA-4odjA:56.28"],["4NDN_A_SAMA407_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.37A","4ndnB-4odjA:59.6","4ndnB-4odjA:56.28"],["4NDN_C_SAMC405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","4ndnC-4odjA:53.3","4ndnC-4odjA:56.28"],["4NDN_C_SAMC405_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.20A","4ndnD-4odjA:59.7","4ndnD-4odjA:56.28"],["4ODJ_A_SAMA500_0","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.00A","4odjA-4odjA:70.0","4odjA-4odjA:100.00"],["4QA0_A_SHHA404_2","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",3,"PRO A 156;MET A 155;TYR A 279","None","0.77A","4qa0B-4odjA:undetectable","4qa0B-4odjA:20.98"],["4QA0_B_SHHB404_1","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",3,"PRO A 156;MET A 155;TYR A 279","None","0.75A","4qa0A-4odjA:undetectable","4qa0A-4odjA:20.98"],["4QA2_A_SHHA404_2","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",3,"PRO A 156;MET A 155;TYR A 279","None","0.86A","4qa2B-4odjA:undetectable","4qa2B-4odjA:21.44"],["4QVW_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"GLY A 388;GLY A 387;SER A 386;ASP A 170;SER A  32","None","1.07A","4qvwK-4odjA:undetectable;4qvwL-4odjA:undetectable","4qvwK-4odjA:21.65;4qvwL-4odjA:18.99"],["4QVW_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",5,"GLY A 388;GLY A 387;SER A 386;ASP A 170;SER A  32","None","1.07A","4qvwY-4odjA:undetectable;4qvwZ-4odjA:undetectable","4qvwY-4odjA:21.65;4qvwZ-4odjA:18.99"],["5A1I_A_ADNA407_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","5a1iA-4odjA:60.2","5a1iA-4odjA:56.28"],["5A1I_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.25A","5a1iA-4odjA:60.2","5a1iA-4odjA:56.28"],["5JH7_B_6K9B503_1","TUBULIN ALPHA-1B CHAIN;TUBULIN BETA-2B CHAIN","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",4,"LEU A 231;VAL A 234;GLU A 168;ILE A 221","None","1.20A","5jh7C-4odjA:undetectable","5jh7C-4odjA:21.90"],["5T8S_B_SAMB402_0","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"ALA A  60;GLU A  75;GLN A 118;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.18A","5t8sA-4odjA:57.9","5t8sA-4odjA:50.82"],["5T8S_B_SAMB402_1","S-ADENOSYLMETHIONINE SYNTHASE","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.15A","5t8sB-4odjA:55.3","5t8sB-4odjA:50.82"],["6FBN_B_SAMB401_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",6,"ALA A  60;GLU A  75;ILE A 122;ASP A 139;LYS A 297;ILE A 330","None","0.32A","6fbnA-4odjA:58.0","6fbnA-4odjA:56.04"],["6FBN_B_SAMB401_1","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.24A","6fbnB-4odjA:52.0","6fbnB-4odjA:56.04"],["6FBO_A_ADNA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.23A","6fboA-4odjA:60.4","6fboA-4odjA:12.32"],["6FBP_B_ADNB404_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.31A","6fbpA-4odjA:60.1;6fbpB-4odjA:53.6","6fbpA-4odjA:12.32;6fbpB-4odjA:12.32"],["6FCB_A_SAMA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.32A","6fcbA-4odjA:59.9","6fcbA-4odjA:56.28"],["6FCD_A_ADNA405_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",8,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 214;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 ( 4.0A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.23A","6fcdA-4odjA:60.0","6fcdA-4odjA:12.32"],["6FGD_A_ACTA821_0","GEPHYRIN","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",3,"ARG A 392;PHE A 390;GLY A 388","None","0.73A","6fgdA-4odjA:undetectable","6fgdA-4odjA:21.35"],["6G6R_A_SAMA406_0","S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2","4odj","S-ADENOSYLMETHIONINE SYNTHASE","Cryptosporidium hominis",7,"HIS A  34;PRO A  35;ASP A 187;LYS A 189;SER A 255;PHE A 258;ASP A 266","SAM A 500 ( 3.8A);SAM A 500 (-4.3A);SAM A 500 (-2.8A);3PO A 501 ( 2.7A);SAM A 500 (-2.7A);SAM A 500 (-3.5A);SAM A 500 (-3.3A)","0.25A","6g6rA-4odjA:60.3","6g6rA-4odjA:56.28"]]